ANDA 76620, held by Actavis Labs Fl Inc. Fosinopril Sodium.
As of Nov 16, 2026, ANDA 76620 (Fosinopril Sodium), held by Actavis Labs Fl Inc, was first approved by FDA on Oct 15, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 15, 2004 | Original application | Approved | None posted |
| Fosinopril Sodium10MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium20MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium40MG · tablet;oral | Fosinopril Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters